ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 699757 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 699757; 2) Community: the network communities that were significantly associated with the response to NSC 699757; 3) Molecule: the relationships between components within communities and NSC 699757; 4) MDR: the compounds that were significantly associated with the NSC 699757.

NSC Compound Enrichment Correlation
NSC 303861 L-Cysteine analog 0.0385613993886001 0.59635652
NSC 349622 Cytovaricin 0.0385613993886001 -0.077929327
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.0385613993886001 0.50087194
NSC 371777 Null 0.0385613993886001 0.15076942
NSC 380856 ACRONYCINE, 2-NITRO 0.0385613993886001 0.18261652
NSC 42972 Null 0.0385613993886001 0.47535279
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.0385613993886001 0.49728112
NSC 615291 Bizelesin 0.0385613993886001 0.11998354
NSC 630606 1-Piperidinecarboxylic acid, 3,5-bis(phenylmethylene)- 4-oxo-, 4-methylphenyl ester 0.0385613993886001 0.48927741
NSC 633113 [1,2,3,4]Tetrathiocino[5,6-d:7,8-d']diimidazole- 2,9-dithione, 1,3,8,10-tetraethyl-1,2,3,8,9,10-hexahydro- 0.0385613993886001 0.60740391
Total:67  Current:44    [First] [Prev] [Next] [Last]